The Future of HIV-1 Therapeutics [electronic resource] Resistance Is Futile? / edited by Bruce E. Torbett, David S. Goodsell, Douglas D. Richman.

This volume thoroughly covers HIV-1 antiretrovirals currently in clinical use, together with their advantages and limitations. HIV-1 inhibitor resistance is discussed in detail, and critical assessments as to what will be required of future antiretrovirals in order to halt viral replication, reduce...

Full description

Bibliographic Details
Uniform Title:Current Topics in Microbiology and Immunology, 2196-9965 ; 389
Corporate Author: SpringerLink (Online service)
Other Authors: Torbett, Bruce E. (Editor)
Goodsell, David S. (Editor)
Richman, Douglas D. (Editor)
Language:English
Published: Cham : Springer International Publishing : Imprint: Springer, 2015.
Edition:1st ed. 2015.
Series:Current Topics in Microbiology and Immunology, 389
Subjects:
Medical microbiology.
Virology.
Diseases.
Online Access:
Springer English/International eBooks 2015 - Full Set: 2015 (Springer Link)
Variant Title:
Future of Hiv-1 Therapeutics: Resistance is Futile?
Format: Electronic eBook
Description
Summary:
This volume thoroughly covers HIV-1 antiretrovirals currently in clinical use, together with their advantages and limitations. HIV-1 inhibitor resistance is discussed in detail, and critical assessments as to what will be required of future antiretrovirals in order to halt viral replication, reduce viral resistance, and alter the state of viral latency are presented. Experts at the forefront of HIV-1 research provide overviews of approaches from the fields of virology, chemical biology and structural biology for obtaining small molecule inhibitors that target viral regulatory and structural components at multiple points in the viral lifecycle. The individual chapters will appeal to scientists and clinicians alike.
ISBN:9783319185187 (online)
ISSN:2196-9965 ;